Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

346 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Rini BI, Paintal A, Vogelzang NJ, Gajewski TF, Stadler WM. Rini BI, et al. J Immunother. 2002 May-Jun;25(3):269-77. doi: 10.1097/00002371-200205000-00010. J Immunother. 2002. PMID: 12000869 Clinical Trial.
A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.
Desai AA, Vogelzang NJ, Rini BI, Ansari R, Krauss S, Stadler WM. Desai AA, et al. Cancer. 2002 Oct 15;95(8):1629-36. doi: 10.1002/cncr.10847. Cancer. 2002. PMID: 12365009 Clinical Trial.
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.
Rini BI, Halabi S, Taylor J, Small EJ, Schilsky RL; Cancer and Leukemia Group B. Rini BI, et al. Clin Cancer Res. 2004 Apr 15;10(8):2584-6. doi: 10.1158/1078-0432.ccr-03-0605. Clin Cancer Res. 2004. PMID: 15102658 Clinical Trial.
Practice and progress in kidney cancer: methodology for novel drug development.
Rini BI, Weinberg V, Small EJ. Rini BI, et al. J Urol. 2004 Jun;171(6 Pt 1):2115-21. doi: 10.1097/01.ju.0000113728.46439.02. J Urol. 2004. PMID: 15126769 Review.
VEGF-targeted therapy in metastatic renal cell carcinoma.
Rini BI. Rini BI. Oncologist. 2005 Mar;10(3):191-7. doi: 10.1634/theoncologist.10-3-191. Oncologist. 2005. PMID: 15793222 Retracted. Review.
Renal cell carcinoma.
Rathmell WK, Godley PA, Rini BI. Rathmell WK, et al. Curr Opin Oncol. 2005 May;17(3):261-7. doi: 10.1097/01.cco.0000155007.51495.d6. Curr Opin Oncol. 2005. PMID: 15818172 Review.
346 results
Jump to page
Feedback